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Insurance Reform Work Group – Open Stakeholder Meeting 5/11/2012 
Summaries of Topics and Discussion Questions 
 
Open Enrollment/Special Enrollment 
 
State provision:  Chapter 288 of the Acts of 2010 defines the following open enrollment periods for the 
individual and small group market (which doesn’t include Young Adult Plans or CommCare): 
 
For 2011: (two open enrollment periods) 
1.  Jan 1, 2011 - Feb 15, 2011  (6 weeks) and 
2.  July 1, 2011 - Aug 15, 2011 (6 weeks) 
 
For 2012 and after: (one yearly open enrollment period) 
July 1 - August 15 * (6 weeks) 
 
* The July 1 - August 15 open enrollment period allows people to enroll into plans for coverage effective 
in August or September 
 
ACA provision:  The Exchange final rule defines the following open enrollment periods: 
 
For benefit years from Jan 1, 2014 - Dec 31, 2014: 
October 1, 2013 - March 31, 2014 (6 months)*** 
 
For benefit years on or after Jan 1, 2015: 
October 15th - December 7th (8 weeks) of the preceding calendar year 
 
***  According to §155.410 of the final rule: 
o Between the 1st and 15th day of the initial open enrollment period: coverage is for the 1st day of 
the following month;  
 
o Between the 16th and last month (for any month between December 2013 and March 31, 2014):  
coverage is for the 1st day of the 2nd following month. 
 
o An exchange has the option of having earlier effective coverage dates (if the exchange can 
demonstrate to HHS that all of its participating QHP issuers agree to a shorter  timeframe) 
 
Special enrollment periods:  people are allowed to enroll outside of the defined open enrollment 
periods for a list of different reasons.  The list of reasons is different in state law vs. the ACA. 
 
Questions for Stakeholder Feedback: 
• What is the impact of the different open enrollment dates in state law vs. the ACA? 
• Should non-Exchange plans should have the same open enrollment period as the Exchange plans? 
• How should consumers be informed of open enrollment changes? Learning from the state’s 
transition to one open enrollment period, what might be dome differently for the transition in 
2013-2014? 
 
 
 
Termination of Coverage in a Qualified Health Plan 
 
According to §155.430(d) of the Exchange final rule, an individual must be allowed to voluntarily 
terminate coverage in a Qualified Health Plan (QHP). In the case of voluntary termination of coverage by 
the individual, the effective date for the termination of coverage is either: (1) the date requested by the 
enrollee if “appropriate notice”is provided to the Exchange, where appropriate notice is defined as 14 
days; (2) fourteen days after the termination request without reasonable notice; (3) in fewer than 
fourteen days if the individual requests an earlier termination date and the QHP issuer can 
accommodate it; or, (4) the last day of coverage before enrollment in Medicaid, CHIP, or the Basic 
Health Plan begins.  
 
The final rule allows the Exchange to initiate termination of coverage if: 
• The enrollee is no longer eligible for coverage in a QHP through the Exchange. 
• The enrollee does not pay premiums and, if applicable, the 3-month grace period required for 
individuals receiving APTCs has been exhausted as described below. The last day of coverage for 
non-payment of premiums for enrollees not receiving APTCs is in accordance with State law. 
• The enrollee's coverage is rescinded. 
• The QHP terminates or is decertified. 
• The enrollee changes from one QHP to another during an annual open enrollment period or 
special enrollment period. 
 
§156.270 of the final rule requires a 90 grace period for individuals who receive APTCs before they can 
be terminated for non-payment of premium. The three month grace period applies whenever the issuer 
has received less than the full amount of the enrollee’s share of the premium for a given month. 
 
QHP issuers must pay all claims during the initial month of the grace period. The final rule permits 
issuers to either pay or pend claims in the second and third months. If the enrollee settles all 
outstanding payments by the end of the grace period, pended claims must be paid. If the enrollee does 
not settle all outstanding payments by the end of the grace period, claims for the second and third 
months could be denied. Issuers must notify providers who submit claims for services rendered during 
the second and third months of the grace period that claims will be pended and potentially not 
reimbursed.  
 
Questions for Stakeholder Feedback: 
• Are there any concerns with allowing mid-month terminations? 
• Are there any concerns with the list of reasons an Exchange or QHP issuer is allowed to initiate 
termination of coverage provided in the final rule? 
• Are there any administrative concerns with pending claims during the second and third months 
of the 90 grace period? 
  
Coverage for Individuals Participating in Approved Clinical Trials 
 
ACA Provision 
Section 2709 of the Affordable Care Act, as added by Section 10103, prohibits insurers from dropping 
coverage of an individual because an individual chooses to participate in a clinical trial or from denying 
that individual coverage for routine care that the insurer would otherwise provide just because an 
individual is enrolled in a clinical trial.  This provision applies to all clinical trials that treat cancer or other 
life-threatening diseases.  Section 2709 provides specific guidance on coverage, definition of a qualified 
individual, limitations on coverage, definition of an approved clinical trial, and definition of life-
threatening condition. 
 
Current Massachusetts Law/Regulations 
An insurer may not deny an insured coverage for covered services that the plan would otherwise 
provide just because an individual is enrolled in a clinical trial.  This provision applies to all clinical trials 
that treat cancer.  M.G.L. cc. 175 §110L. 176A §8X, 176B §4X, and 176G §4P along with DOI Bulletin 
2002-13 provide specific guidance on coverage, definition of patient care service and definition of 
qualified clinical trial. 
 
Questions for Stakeholder Feedback: 
• What, if any, concerns in administering both the state and the ACA guidelines? 
• Do you see that legislative changes may be necessary in order for health plans to administer 
both requirements?? 
• If you feel that legislation is not necessary, would you require any further guidance from the 
DOI? 
• Any other questions/comments with respect to the various options? 
 
